ANI Pharmaceuticals, Inc.
ANIP
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; and potent prā¦ read more
Healthcare
Drug ManufacturersāSpecialty & Generic
26 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$79.24
Price-1.48%
-$1.19
1Y
Price
Market Cap
$1.801b
Small
Price/Earnings 3y Avg5y Avg
9.6x
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.+26.9%
EBITDA Margin+10.6%
Net Profit Margin+16.6%
Free Cash Flow Margin+26.9%
EBITDA Margin+10.6%
Net Profit Margin+16.6%
Free Cash Flow MarginRevenue
$923.706m
+34.6%
1y CAGR+38.2%
3y CAGR+40.3%
5y CAGREarnings
$89.665m
+305.6%
1y CAGR+82.1%
3y CAGR+58.5%
5y CAGREPS
$3.94
+256.7%
1y CAGR+59.0%
3y CAGR+46.8%
5y CAGRBook Value
$562.300m
$1.422b
Assets$859.670m
Liabilities$327.764m
DebtDebt to Assets
23.1%
2x
Debt to EBITDAFree Cash Flow
$160.353m
+187.5%
1y CAGR+148.4%
3y CAGR+77.6%
5y CAGRNo items found.
Press Releases
Statements and updates from the company